Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (unaudited) - USD ($)
Total
Adjustments
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Deficit
Total The Joint Corp. stockholders' equity
Non-controlling interest
Balance, beginning at Dec. 31, 2019 $ 5,504,592   $ 13,899 $ 39,454,937 $ (111,041) $ (33,853,303) $ 5,504,492 $ 100
Balance, beginning (in shares) at Dec. 31, 2019     13,898,694   (15,762)      
Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 250,392     250,392     250,392  
Issuance of restricted stock 0   $ 16 (16)        
Issuance of vested restricted stock (in shares)     15,578          
Exercise of stock options 140,899   $ 35 140,864     140,899  
Exercise of stock options (in shares)     35,500          
Purchases of treasury stock under employee stock plans (3,774)       $ (3,774)   (3,774)  
Purchase of treasury stock under employee stock plans (in shares)         251      
Net income 814,947         814,947 814,947  
Balance, ending at Mar. 31, 2020 6,707,056   $ 13,950 39,846,177 $ (114,815) (33,038,356) 6,706,956 100
Balance, ending (in shares) at Mar. 31, 2020     13,949,772   (16,013)      
Balance, beginning at Dec. 31, 2019 5,504,592   $ 13,899 39,454,937 $ (111,041) (33,853,303) 5,504,492 100
Balance, beginning (in shares) at Dec. 31, 2019     13,898,694   (15,762)      
Stockholders' Equity [Roll Forward]                
Net income 2,534,491              
Balance, ending at Sep. 30, 2020 9,205,185   $ 14,073 40,625,128 $ (115,303) (31,318,813) 9,205,085 100
Balance, ending (in shares) at Sep. 30, 2020     14,073,244   (16,043)      
Balance, beginning at Mar. 31, 2020 6,707,056   $ 13,950 39,846,177 $ (114,815) (33,038,356) 6,706,956 100
Balance, beginning (in shares) at Mar. 31, 2020     13,949,772   (16,013)      
Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 216,081     216,081     216,081  
Issuance of restricted stock 0   $ 31 (31)        
Issuance of vested restricted stock (in shares)     30,882          
Exercise of stock options 247,021   $ 62 246,959     247,021  
Exercise of stock options (in shares)     62,200          
Net income 115,584         115,584 115,584  
Balance, ending at Jun. 30, 2020 7,285,742   $ 14,043 40,309,186 $ (114,815) (32,922,772) 7,285,642 100
Balance, ending (in shares) at Jun. 30, 2020     14,042,854   (16,013)      
Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 212,234     212,234     212,234  
Issuance of restricted stock 0   $ 4 (4)        
Issuance of vested restricted stock (in shares)     4,281          
Exercise of stock options 103,738   $ 26 103,712     103,738  
Exercise of stock options (in shares)     26,109          
Purchases of treasury stock under employee stock plans (488)       $ (488)   (488)  
Purchase of treasury stock under employee stock plans (in shares)         30      
Net income 1,603,959         1,603,959 1,603,959  
Balance, ending at Sep. 30, 2020 9,205,185   $ 14,073 40,625,128 $ (115,303) (31,318,813) 9,205,085 100
Balance, ending (in shares) at Sep. 30, 2020     14,073,244   (16,043)      
Balance, beginning at Dec. 31, 2020 20,535,175 $ (215,908) $ 14,174 41,350,001 $ (143,111) (20,685,989) 20,535,075 100
Balance, beginning (in shares) at Dec. 31, 2020     14,174,237   (17,167)      
Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 246,494     246,494     246,494  
Issuance of restricted stock 0   $ 8 (8)        
Issuance of vested restricted stock (in shares)     7,879          
Exercise of stock options 620,776   $ 106 620,670     620,776  
Exercise of stock options (in shares)     105,995          
Purchases of treasury stock under employee stock plans (618,154)       $ (618,154)   (618,154)  
Purchase of treasury stock under employee stock plans (in shares)         13,619      
Net income 2,314,694         2,314,694 2,314,694  
Balance, ending at Mar. 31, 2021 23,098,985   $ 14,288 42,217,157 $ (761,265) (18,371,295) 23,098,885 100
Balance, ending (in shares) at Mar. 31, 2021     14,288,111   (30,786)      
Balance, beginning at Dec. 31, 2020 20,535,175 $ (215,908) $ 14,174 41,350,001 $ (143,111) (20,685,989) 20,535,075 100
Balance, beginning (in shares) at Dec. 31, 2020     14,174,237   (17,167)      
Stockholders' Equity [Roll Forward]                
Net income 6,935,751              
Balance, ending at Sep. 30, 2021 29,070,739   $ 14,444 43,657,273 $ (850,839) (13,775,139) 29,045,739 25,000
Balance, ending (in shares) at Sep. 30, 2021     14,444,982   (31,643)      
Balance, beginning at Mar. 31, 2021 23,098,985   $ 14,288 42,217,157 $ (761,265) (18,371,295) 23,098,885 100
Balance, beginning (in shares) at Mar. 31, 2021     14,288,111   (30,786)      
Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 283,564     283,564     283,564  
Issuance of restricted stock 0   $ 4 (4)        
Issuance of vested restricted stock (in shares)     4,218          
Exercise of stock options 641,787   $ 113 641,674     641,787  
Exercise of stock options (in shares)     113,819          
Net income 2,683,961         2,683,961 2,683,961  
Balance, ending at Jun. 30, 2021 26,708,297   $ 14,405 43,142,391 $ (761,265) (15,687,334) 26,708,197 100
Balance, ending (in shares) at Jun. 30, 2021     14,406,148   (30,786)      
Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 296,850     296,850     296,850  
Issuance of restricted stock 0   $ 4 (4)        
Issuance of vested restricted stock (in shares)     4,280          
Exercise of stock options 218,071   $ 35 218,036     218,071  
Exercise of stock options (in shares)     34,554          
Purchases of treasury stock under employee stock plans (89,574)       $ (89,574)   (89,574)  
Purchase of treasury stock under employee stock plans (in shares)         857      
Change in redemption value of noncontrolling interest 0         (24,900) (24,900) 24,900
Net income 1,937,095         1,937,095 1,937,095  
Balance, ending at Sep. 30, 2021 $ 29,070,739   $ 14,444 $ 43,657,273 $ (850,839) $ (13,775,139) $ 29,045,739 $ 25,000
Balance, ending (in shares) at Sep. 30, 2021     14,444,982   (31,643)